Clinical Trial Update: Panitumumab After Resection of Liver Metastases From Colorectal Cancer in KRAS Wild-type Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating panitumumab after resection of liver metastases in patients with KRAS wild-type colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Colorectal Cancer with Liver Metastases

Drugs mentioned

• Panitumumab (panitumumab)

Snippet

Sponsor: PD Dr. med. Volker Heinemann | Conditions: Colorectal Cancer, KRAS Wildtype | Phase 2 | Status: UNKNOWN